论文部分内容阅读
目的:探讨不同剂量米非司酮治疗子宫肌瘤的临床价值。方法:随机将我院收治60例子宫肌瘤患者分为观察组和对照组各30例。观察组为小剂量组,对照组为大剂量组。结果:观察组总有效率为93.33%,不良反应率为6.67%;对照组总有效率为96.67%,不良反应率为33.33%。两组患者总有效率无明显差异(P>0.05),对照组不良反应率明显高于观察组(P<0.05)。结论:采用小剂量米非司酮治疗子宫肌瘤患者具有显著效果,值得临床推广。
Objective: To investigate the clinical value of different doses of mifepristone in the treatment of uterine fibroids. Methods: Randomly treated 60 patients with uterine fibroids in our hospital were divided into observation group and control group of 30 cases. The observation group was a small dose group and the control group was a high dose group. Results: The total effective rate was 93.33% in the observation group and 6.67% in the adverse reaction group. The total effective rate in the control group was 96.67% and the adverse reaction rate was 33.33%. There was no significant difference in the total effective rate between the two groups (P> 0.05). The adverse reaction rate in the control group was significantly higher than that in the observation group (P <0.05). Conclusion: The use of low-dose mifepristone treatment of patients with uterine fibroids has a significant effect, it is worth clinical promotion.